Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 4
2019 6
2020 10
2021 18
2022 18
2023 15
2024 19
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
Pasta A, Pieri G, Plaz Torres MC, Missale G, Foschi FG, Piscaglia F, Boninsegna S, Mega A, Cazzagon N, Pelizzaro F, Viganò M, Trevisani F, Bucci L, Azzaroli F, Brunetto MR, Campani C, Celsa C, Ghittoni G, Magalotti D, Martini A, Morisco F, Nardone G, Ponziani FR, Sacco R, Sacerdoti D, Saitta C, Sangiovanni A, Lani L, Svegliati-Baroni G, Vidili G, Vitale A, Giannini EG; Italian Liver Cancer (ITA.LI.CA) Group. Pasta A, et al. Among authors: celsa c. Dig Dis Sci. 2025 May 3. doi: 10.1007/s10620-025-09064-1. Online ahead of print. Dig Dis Sci. 2025. PMID: 40317369
Hepatocellular carcinoma in people living with HIV.
Am Fulgenzi C, Dalla Pria A, Leone AG, Celsa C, Cabibbo G, Scheiner B, Pinter M, D'Alessio A, Zhao Y, Brau N, Bower M, Pinato DJ. Am Fulgenzi C, et al. Among authors: celsa c. J Hepatol. 2025 Apr 30:S0168-8278(25)00287-9. doi: 10.1016/j.jhep.2025.04.028. Online ahead of print. J Hepatol. 2025. PMID: 40316049 Free article. Review.
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.
Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D'Alessio A. Stefanini B, et al. Among authors: celsa c. J Hepatocell Carcinoma. 2025 Apr 4;12:671-683. doi: 10.2147/JHC.S462701. eCollection 2025. J Hepatocell Carcinoma. 2025. PMID: 40201222 Free PMC article.
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
Celsa C, Cabibbo G, Fulgenzi CAM, Battaglia S, Enea M, Scheiner B, D'Alessio A, Manfredi GF, Stefanini B, Nishida N, Galle PR, Schulze K, Wege H, Ciccia R, Hsu WF, Vivaldi C, Wietharn B, Lin RP, Pirozzi A, Pressiani T, Dalbeni A, Natola LA, Auriemma A, Rigamonti C, Burlone M, Parisi A, Huang YH, Lee PC, Ang C, Marron TU, Pinter M, Cheon J, Phen S, Singal AG, Gampa A, Pillai A, Roehlen N, Thimme R, Vogel A, Soror N, Ulahannan S, Sharma R, Sacerdoti D, Pirisi M, Rimassa L, Lin CY, Saeed A, Masi G, Schönlein M, von Felden J, Kudo M, Cortellini A, Chon HJ, Cammà C, Pinato DJ. Celsa C, et al. Hepatology. 2025 Mar 1;81(3):837-852. doi: 10.1097/HEP.0000000000001026. Epub 2024 Jul 19. Hepatology. 2025. PMID: 39028886
Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death.
Cabibbo G, Celsa C, Battaglia S, Enea M, Di Maria G, Grova A, Ciccia R, Manfredi GF, Iavarone M, Vogel A, Singal AG, Reig M, Pinato DJ, Cammà C. Cabibbo G, et al. Among authors: celsa c. Clin Cancer Res. 2025 Feb 3;31(3):543-550. doi: 10.1158/1078-0432.CCR-24-2582. Clin Cancer Res. 2025. PMID: 39576248
86 results